Cl. Bender et al., Pseudomonas syringae phytotoxins: Mode of action, regulation, and biosynthesis by peptide and polyketide synthetases, MICRO M B R, 63(2), 1999, pp. 266
Coronatine, syringomycin, syringopeptin, tabtoxin, and phaseolotoxin are th
e most intensively studied phytotoxins of Pseudomonas syringae, and each co
ntributes si,significantly to bacterial virulence in plants. Coronatine fun
ctions partly as a mimic of methyl jasmonate, a hormone synthesized by plan
ts undergoing biological stress. Syringomycin and syringopeptin form pol es
in plasma membranes, a process that lends to electrolyte leakage. Tabtoxin
and phaseolotoxin are strongly antimicrobial and function by inhibiting gl
utamine synthetase and ornithine carbamoyltransferase,, respectively. Genet
ic analysis has revealed the mechanisms responsible for toxin biosynthesis.
Coronatine biosynthesis requires the cooperation of polyketide and peptide
synthetases for the assembly of the coronafacic and coronamic acid moietie
s, respectively. Tabtoxin is derived fi-om the lysine biosynthetic pathway
whereas syringomycin syringopeptin, and phaseolotoxin? biosynthesis require
s peptide synthetases. Activation of phytotoxin synthesis is controlled by
diverse environmental factors including plant signal molecules and temperat
ure. Genes involved in the regulation of phytotoxin synthesis have been loc
ated within the coronatine and syringomycin gene clusters; however, additio
nal regulatory genes are required for the synthesis of these and other phyt
otoxins. Global regulatory genes such as gacS modulate phytotoxin productio
n in certain pathovars, indicating the complexity of the regulatory circuit
s controlling phytotoxin synthesis. The coronatine and syringomycin gene cl
usters have been intensively characterized and show potential for construct
ing modified polyketides and peptides. Genetic reprogramming of peptide and
polyketide synthetases has been successful and portions of the coronatine
and syringomycin gene clusters could be valuable resources in developing ne
w antimicrobial agents.